Détail d'une collection
|
Documents disponibles dans la collection (37)
Rapport
This publication presents the data and findings of the risk assessment on 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC), carried out by the extended Scientific Committee of the EMCDDA on 19 November 2021. On the b[...]Rapport
This publication presents the data and findings of the risk assessment on 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2021. On the b[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on 4F-MDMB-BICA. The report is intended for policymakers and decision-makers in the institu[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant [...]Rapport
This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 N[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 No[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of th[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7[...]Rapport
This publication presents the data and findings of the risk assessment on methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2[...]Rapport
This publication presents the data and findings of the risk assessment on 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017.[...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018.[...]Rapport
L. A. KING ; R. SEDEFOV ; Europol | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2007ENGLISH : The purpose of these guidelines is to address the measures introduced by Council Decision 2005/387/HA. They are concerned only with the first stage, i.e. the early-warning system and information exchange, and replace the earlier guid[...]Brochure
ENGLISH : Within the framework of the joint Action of 16 June 1997, the Early-warning System (EWS) aims to create a mechanism for the rapid exchange of information on the production, traffic, use and risks of new synthetic drugs. Taking into a[...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide (furanylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 23 May 2017. On the ba[...]Rapport
FRANÇAIS : En juin 1997, le Conseil de l'Union Européenne voulant suppléer aux différences de législation sur les nouvelles drogues de synthèse dans les Etats membres de l'Union Européenne, a adopté une action commune permettant l'échange d'in[...]Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. SEDEFOV ; A. ALMEIDA ; R. CHRISTIE ; P. DUQUE ; A. GALLEGOS ; R. JORGE ; J. DE MORAIS | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2020This publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on [...]Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en-PINACA. The report is intended for policymakers and decision-makers in the inst[...]Rapport
OEDT = EMCDDA ; A. M. DINES ; D. M. WOOD ; P. I. DARGAN | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (MDPV), that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]Rapport
OEDT = EMCDDA ; D. M. WOOD ; P. I. DARGAN | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]Rapport
This publication presents the data and findings of the risk assessment on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. O[...]Rapport
This publication presents the data and findings of the risk assessment on MT-45 (1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of the publicatio[...]Rapport
OEDT = EMCDDA ; S. ELLIOTT ; S. BRANDT | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe), that was conducted by the Scientific Committee of the EMCDDA. Concer[...]Rapport
The risk-assessment reports on the synthetic drugs 2C-I; 2C-T-2 and 2C-T-7 were submitted by the EMCDDA to the European Council and Commission on 4 April 2003. The reports were drawn up at a meeting in Lisbon from 31 March to 1 April under the a[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921), that was conducted by the Scientific Committee of the EMCDDA. Concern[...]Rapport
FRANÇAIS : L'Observatoire européen des drogues et toxicomanies présente les résultats de son étude sur l'évolution des risques concernant la 4-méthylthioamphétamine ou 4-MTA. Cette nouvelle drogue de synthèse est connue des autorités des Etats[...]Rapport
ENGLISH : This publication presents the findings of the formal risk assessment on BZP, produced in 2007 by the Scientific Committee of the EMCDDA, with participation of additional experts from the European Commission, Europol and the EMEA. The[...]Rapport
FRANÇAIS : L'Observatoire européen des drogues et toxicomanies présente les résultats de l'évaluation des risques associés à l'acide gamma-hydroxybutyrate (GHB) menées en 2000 dans le cadre de l'action commune sur les nouvelles drogues de synt[...]Rapport
FRANÇAIS : L'Observatoire européen des drogues et toxicomanies présente les résultats de l'évaluation des risques associés à la kétamine menées en 2000 dans le cadre de l'action commune sur les nouvelles drogues de synthèse. Cette publication [...]Rapport
FRANÇAIS : Cette publication présente le rapport établi consécutivement à la rencontre qui s'est déroulée les 9 et 10 Novembre 1998 à Lisbonne entre le comité scientifique de l'OEDT, les experts des 15 états de l'Union Européenne, des représen[...]Rapport
FRANÇAIS : Le rapport traite, entre autres, de : * la description chimique et physique de la méphédrone ainsi que de ses mécanismes d'action ; * les risques sur la santé associés à la méphédrone ; * les risques sociaux ; * des informations [...]Rapport
ENGLISH : Unlike ketamine and GHB, but similar to MBDB and 4-MTA, PMMA is one of the numerous "new synthetic drugs" with no legitimate therapeutic use that are described in Shulgin's Pihkal (Shulgin and Shulgin, 1991). PMMA is a structural hyb[...]Rapport
ENGLISH : Since the adoption by the Council in June 1997 of the joint action on the information exchange, risk assessment and control of new synthetic drugs, TMA-2 (2,4,5-trimethoxyamphetamine) is the ninth substance to be subjected to risk as[...]Rapport
The principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment, by using a semi-quantitative assessment procedure. This publication is a revision of the "Guidelines for [...]Rapport
This publication presents the data and findings of the risk assessment on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (THF-F), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. In March 20[...]